Investors

Company Profile

Founded in November 2012, ObsEva is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions that compromise a woman’s reproductive health and pregnancy. We believe our expertise has led to the development of new and innovative therapies that have the potential to improve patient outcomes in reproductive health.

Financial Reports

Q2 Report 2019

August 7, 2019

Q1 Report 2019

May 9, 2019

Investor presentations

The H.C. Wainwright 21st Annual Global Investment in NYC – September 10th 2019

Wedbush Presentation August 2019 in NYC

KOL Event in NYC July 2019

Jefferies Healthcare Conference Presentation – June 2019

ObsEva Investor Presentation – April 2019

ObsEva Short Report 2018

Press Releases

ObsEva SA Announces Appointments to its Board of Directors and Scientific Advisory Board

press release

January 17, 2014

Geneva, Switzerland, 17 January 2014 – ObsEva, a Swiss-based, speciality biopharmaceutical company dedicated to the development of innovative drugs for…

Read more

ObsEva SA announces CHF 32 Million Series A funding from leading Venture Capital firms and a license agreement with MerckSerono

press release

August 29, 2013

Geneva, Switzerland, 29 August 2013 – ObsEva today announced the closing of a CHF 32 million Series-A financing round (€25.6 million)….

Read more

Other ObsEva press releases

press release

January 1, 2000

Learn more

Read more
1 37 38 39

General Meetings

ObsEva Annual General Meeting 2019

May 8, 2019

Read more

ObsEva Annual General Meeting 2018

May 9, 2018

Read more
1 2

Upcoming Events

Year End 2019 Financial Results week of 02 March 2020

Event

March 2, 2020


Read more

Third Quarter 2019 Financial Results week of 04 November 2019

Event

November 4, 2019


Read more
 

Contacts

ObsEva Switzerland Office

+41 (0)22 552 3840


contact@obseva.ch

ObsEva U.S. Office

+1 857 972 9364


contact@obseva.ch

Media Switzerland & Europe

Christophe Lamps
Dynamics Group
+41 79 476 26 87

cla@dynamicsgroup.ch

Media United States

Marion Janic
RooneyPartners LLC
+1 212-223-4017

mjanic@rooneyco.com

Investor relations




ir@obseva.ch

Clinical studies




clinicaltrials@obseva.ch

HR Office

Charlotte Cadoux


charlotte.cadoux@obseva.ch

CEO Office

+41 (0)22 552 1550


shauna.dillon@obseva.ch

 

Sign up for news

 
 

* Type:


InvestorHCPNursePayerHospital PharmacistRetail PharmacistOther












Read our privacy policy here.